Recent Updates
Recently added Catalysts
WAT Positive Sentiment

Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors News Summary: New Alliance™ iS Bio High Performance Liquid Chromatography (HPLC) System helps biopharmaceutical QC laboratories boost efficiency and...

Key Takeaway: Waters Corporation has launched the Alliance iS Bio HPLC System, designed to enhance efficiency in biopharma quality control laboratories. This new system features advanced bio-separation technology and intelligent instrument functionalities that can reduce common errors by up to 40%. It incorporates bio-inert design elements and pairs with Waters' other products for improved chromatography testing and compliance. The system is now available globally and aims to help QC labs meet stringent compliance requirements while boosting productivity.
Price reaction · baseline $339.04 (2024-04-08 close) · hit after-hours · 1 other WAT headline(s) in the window, move may be shared
day 0 close · peak
+1.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Launch of Alliance iS Bio HPLC System aimed at improving QC lab efficiency.
  • System designed to reduce common errors by up to 40%.
  • Enhanced features to meet evolving compliance requirements and improve product release timelines.
  • Integration with existing Waters and third-party chromatography instruments facilitates operational risk management.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~19 mo
Low dilution risk
Lead asset
CYTALUX preoperatively
Phase 2 · Esophageal Cancer

Full Press Release Details

MILFORD, Mass. , and MUNICH , April 9, 2024 /PRNewswire/ -- Analytica 2024 -- Waters Corporation (NYSE: WAT ) today announced the launch of the Alliance iS Bio HPLC System with new capabilities that address the operational and analytical challenges of biopharma quality control (QC) laboratories. The new HPLC system combines advanced bio-separation technology and built-in instrument intelligence features. It is designed to help biopharma QC analysts boost efficiency and eliminate up to 40% of common errors, saving time lost by investigating the source of failed runs and out-of-specification results.
The bio-inert design of the instrument features Waters MaxPeak HPS Technology applied to key internal components including the system flow path to reduce unwanted interactions from metal-adsorbing analytes. The system pairs with Waters QuanRecovery™ Vials and Plates , as well as MaxPeak Premier HPLC Columns with eConnect™ Column Tag Technology , allowing for more confident platform methods that eliminate the need for lengthy column conditioning and method development.
"Many of the challenges that impact productivity and revenues for QC labs come from human error. We collaboratively developed the Alliance iS Bio HPLC System with our customers to address daily routine challenges and help meet more stringent and evolving compliance requirements while working to achieve shorter product release timelines," said Fraser McLeod , Vice President, General Manager, QA/QC, Waters Corporation. "We built every feature of this powerful HPLC platform, including the use of bio-inert surface technology at key sample touchpoints, with simplicity, sophistication and efficiency in mind, to help biopharma QC labs save time and money."
The Alliance iS Bio HPLC System also combines with Waters compliance-ready Empower Chromatography Software to help laboratories collect, manage, and report chromatography test results. It integrates seamlessly with Waters and third-party liquid chromatography instruments to help high-volume QC labs manage operational risk, mitigate disruptions, and increase overall productivity.
The Alliance iS Bio HPLC System is now available globally.
Additional Resources
About Waters Corporation ( www.waters.com )
(NYSE: WAT ), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. With approximately 7,900 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.
Waters, MaxPeak, Alliance, QuanRecovery and eConnect are trademarks of Waters Technologies Corporation.
Contact: Kevin Kempskie Senior Director of Public Relations Waters Corporation [email protected] +1.617.413.4333
i Estimate based on Waters market research in 2022 after surveying 56 global pharmaceutical company QC labs.

Frequently Asked Questions

What is the Alliance iS Bio HPLC System?

It is a new HPLC system designed to enhance biopharma QC lab efficiency and accuracy.

How does the Alliance iS Bio HPLC System reduce errors?

It helps eliminate up to 40% of common errors, minimizing investigation time on failed runs.

What technology does the Alliance iS Bio use?

It features Waters MaxPeak HPS Technology to reduce interactions with metal-adsorbing analytes.

Which software does the system integrate with?

It integrates with Waters compliance-ready Empower Chromatography Software for managing results.

Where is the Alliance iS Bio HPLC System available?

The system is now available globally for biopharma quality control labs.

Last updated: Apr 9, 2024